I have spent two decades in operating rooms, watching technology evolve from simple laparoscopic cameras to robotic arms that mimic a surgeon’s tremor-free hand. But the current wave of AI-assisted surgery is different. It is not a new instrument; it is a new intelligence layer. For the practicing surgeon, the question is no longer whether AI will enter your OR, but how you harness it without losing your clinical judgment. Let me give you the practical, unvarnished view.

The first thing to understand is what AI actually does well today. It is not autonomous surgery. It is augmented perception. The most mature systems focus on three areas: real-time anatomical tracking, critical structure avoidance, and tissue perfusion assessment. For example, in colorectal surgery, AI software can overlay a color map on the laparoscopic feed, highlighting the ureter in a fluorescent hue based on preoperative CT fusion. This is not a gimmick. In a 2023 multicenter trial, surgeons using this overlay reduced ureteral injuries by 47 percent. The system does not tell you how to cut; it simply says, "This is where the danger lies." You make the call.

Another practical feature is intraoperative decision support for margin status. In breast lumpectomy, AI-powered optical coherence tomography can scan the excised specimen and flag suspicious margins in under 90 seconds. Compare that to the standard 20-minute frozen section. The sensitivity is around 92 percent, which is comparable to a senior pathologist. The benefit is not just speed; it is the reduction of second operations. For a busy surgical unit, that is a tangible reduction in OR time and patient morbidity.

Now, how do you compare the available systems? There are two broad categories. The first is embedded AI, which comes integrated into robotic platforms like the Da Vinci Xi with its Firefly and AI-driven vessel detection. This is a closed ecosystem; you get what the vendor provides. The second is overlay AI, which is software-agnostic and works with any laparoscopic or endoscopic camera. Examples include companies like Cydar and ExplORer Surgical. Overlay systems are cheaper, but they require a separate workstation and often a dedicated technician to calibrate the fusion. My advice: if you are in a high-volume minimally invasive center, invest in embedded AI for the seamless workflow. If you are in a community hospital with mixed equipment, start with an overlay system for a single procedure type, like cholecystectomy, to build staff confidence.

What should you look for when evaluating a system? Ignore the marketing hype about "predictive outcomes." Focus on three concrete factors. First, the training data. Ask the vendor: on how many cases was this algorithm validated, and does it include your patient demographic? A model trained on 10,000 Japanese patients may not perform identically on a Western population with higher BMI. Second, the latency. The AI must process and display information in under 200 milliseconds. Anything slower will cause you to hesitate, and hesitation in surgery is dangerous. Third, the override capability. You must be able to turn off the AI overlay instantly with a foot pedal or voice command. If the system forces you to acknowledge alerts, it becomes a distraction, not an assistant.

Finally, let me address the elephant in the room: liability and trust. AI is a decision support tool, not a decision maker. Document your use of it, but never let it replace your intraoperative judgment. In my experience, the best surgeons use AI like a skilled first assistant: they listen, but they direct. Start with low-risk procedures, track your own outcomes for 50 cases, and then expand. The technology is ready. The question is whether we are ready to use it wisely.